ALERT: Your health is top priority. We’re committed to providing reliable COVID-19 resources to keep you informed and safe.
Philips Respironics recalled millions of CPAP and BiPAP machines because degraded PE-PUR sound abatement foam in the machines may break down and cause serious health issues, including: Cancer, respiratory inflammation and other toxic effects. The Philips CPAP recall includes the Philips Dreamstation and other popular CPAP machines.
Editors carefully fact-check all Drugwatch content for accuracy and quality.
Drugwatch has a stringent fact-checking process. It starts with our strict sourcing guidelines.
We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.
Drugwatch.com has provided reliable, trusted information about medications, medical devices and general health since 2008. We’ve also connected thousands of people injured by drugs and medical devices with top-ranked national law firms to take action against negligent corporations.
Our team includes experienced medical writers, award-winning journalists, researchers and certified medical and legal experts. Drugwatch.com is HONCode (Health On the Net Foundation) certified. This means the high-quality information we provide comes from credible sources, such as peer-reviewed medical journals and expert interviews.
The information on Drugwatch.com has been medically and legally reviewed by more than 30 expert contributors, including doctors, pharmacists, lawyers, patient advocates and other health care professionals. Our writers are members of professional associations, including American Medical Writers Association, American Bar Association, The Alliance of Professional Health Advocates and International Society for Medical Publication Professionals.
Philips recalled their CPAP, BiPAP and ventilator devices in June 2021 because of potential health risks. The health risks come from sound abatement foam used to keep the machines quiet and reduce vibration.
The foam may degrade and release particles and toxic gases into the machine’s airways that users may inhale or swallow. Lab tests showed degraded foam and gases contain several toxic and cancer-causing chemicals. Devices that are more than three years old or exposed to high heat or humid environments are more likely to have degraded foam.
The CPAP maker said people who inhale or ingest foam particles or gases may suffer from toxic, carcinogenic and respiratory effects. In Sept.
The recall doesn’t affect all of Philips’ breathing devices. About 80% of the affected devices are CPAP machines and about 20% are ventilators, Philips spokesman Steve Klink told Reuters.
Most of the devices come from Philips’ DreamStation line. The recall affects all serial numbers of the following affected devices manufactured between 2009 and April 26, 2021. More than half of the affected devices are in the U.S., according to Philips.
In January 2022, the FDA announced that Trilogy Evo ventilators and Trilogy Evo repair kits not originally recalled in the July 2021 recall were added to the recalled devices list.
People who use a Philips CPAP can check Philip’s device registration and recall contact information page. This page lists all the recalled machines along with pictures to help users check their devices.
If you aren’t sure if your machine is affected, Philips has set up a registration process that allows users and caregivers to look up the serial number of their device. They also have an instructional video that shows you how to register the device.
Users and caregivers can also call 877-907-7508.
Philips has said they have a comprehensive repair and replace program for recalled CPAP machines. On Sept. 1, 2021, Philips announced that it received its authorization from FDA to begin replacing the problematic foam in affected devices or replacing them with new DreamStation 2 models in the U.S.
Users and caregivers can register for this program on the Philips’ website. The repair and replacement should take about 12 months, Philips said in its Sept. 1, 2021 press release.
Your doctor may tell you to try CPAP alternatives, such as lifestyle changes, nasal decongestants, losing weight or sleep apnea surgery.
If you can’t wait for Philips to replace your CPAP machine, your doctor may recommend that you continue to use your recalled device if the benefits outweigh the risks.
Otherwise, you may choose to get a new CPAP machine from another company. Philips also makes a newer CPAP model called the DreamStation 2, which is not affected by the recall.
In addition to general Philips CPAP side effects, recalled machines pose unique risks because of exposure to particles or gases from degraded foam. These include: Chemical exposure risk, toxic effects, cancer and respiratory issues.
So far, Philips has not received reports of any deaths linked to the device or issues from chemical exposure. Bladder cancer, lung cancer and stomach cancer are among the cancers linked to CPAP.
The FDA recommends people using a recalled Philips CPAP machine talk to their medical provider to discuss their treatment options.
In September 2021, Philips began replacing PE-PUR foam in recalled machines with a silicone foam. But in November 2021, the FDA released a Philips CPAP recall update notifying the public that it found the new silicone foam may still pose a health risk.
Currently, the FDA doesn’t recommend that patients who received a repaired recalled CPAP from Philips stop using their machines with silicone foam. The agency is still investigating the potential risk and will update the public.
Patients who suffered injuries from a recalled device may choose to file a Philips CPAP lawsuit. Family members may also file lawsuits on behalf of their loved ones.
Make sure to speak to a lawyer right away because there is a time limit to file — called a statute of limitations — that is different in each state.
We appreciate your feedback. One of our content team members will be in touch with you soon.
We appreciate your feedback. One of our content team members will be in touch with you soon.
Editors carefully fact-check all Drugwatch content for accuracy and quality.
Drugwatch has a stringent fact-checking process. It starts with our strict sourcing guidelines.
We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.
Drugwatch.com has provided reliable, trusted information about medications, medical devices and general health since 2008. We’ve also connected thousands of people injured by drugs and medical devices with top-ranked national law firms to take action against negligent corporations.
Our team includes experienced medical writers, award-winning journalists, researchers and certified medical and legal experts. Drugwatch.com is HONCode (Health On the Net Foundation) certified. This means the high-quality information we provide comes from credible sources, such as peer-reviewed medical journals and expert interviews.
The information on Drugwatch.com has been medically and legally reviewed by more than 30 expert contributors, including doctors, pharmacists, lawyers, patient advocates and other health care professionals. Our writers are members of professional associations, including American Medical Writers Association, American Bar Association, The Alliance of Professional Health Advocates and International Society for Medical Publication Professionals.
Michelle Llamas has been writing articles and producing podcasts about drugs, medical devices and the FDA for nearly a decade. She focuses on various medical conditions, health policy, COVID-19, LGBTQ health, mental health and women’s health issues. Michelle collaborates with experts, including board-certified doctors, patients and advocates, to provide trusted health information to the public. Some of her qualifications include:
Drugwatch.com writers follow rigorous sourcing guidelines and cite only trustworthy sources of information, including peer-reviewed journals, court records, academic organizations, highly regarded nonprofit organizations, government reports and interviews with qualified experts. Review our editorial policy to learn more about our process for producing accurate, current and balanced content.
Calling this number connects you with a Drugwatch representative. We will direct you to one of our trusted legal partners for a free case review.
Drugwatch's trusted legal partners support the organization's mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.
Join our newsletter to stay up to date on dangerous drugs and devices, keep up on lawsuit and settlement news, learn about FDA recalls, and more.
Keep people safe from potentially harmful drugs, medical devices and procedures by informing them of medical conditions, severe side effects and ways to take action.
This site complies with the HONcode standard for trustworthy health information: Verify here.
Drugwatch is located at: 1 South Orange Ave, Suite 201, Orlando, FL 32801
The information on this website is proprietary and protected. It is not a substitute for professional medical advice, diagnosis or treatment. Any unauthorized or illegal use, copying or dissemination will be prosecuted. Please read our disclaimer for more information about our website.
Drugwatch.com partners with law firms. This website and its content may be deemed attorney advertising. Prior results do not predict a similar outcome. For more information, visit our partners page.
© 2022 Drugwatch.com Privacy Policy / Do Not Sell My Info California Consumer Privacy Act (CCPA) Inquiries Drugwatch.com doesn’t believe in selling customer information. However, as required by the new California Consumer Privacy Act (CCPA), you may record your preference to view or remove your personal information by completing the form below. Request Type Please select a type:Information RequestData Deletion Full Name Full Name Phone Number Email Street Address Zip Code Submit
Drugwatch.com doesn’t believe in selling customer information. However, as required by the new California Consumer Privacy Act (CCPA), you may record your preference to view or remove your personal information by completing the form below.
Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.
If you would like to speak with a Drugwatch representative, please call 888-645-1617